Salesforce
CRM
Coinbase
COIN
Oracle
ORCL
4
Microsoft
MSFT
5
Vale SA
VALE
US Stock MarketDetailed Quotes
LPCN Lipocine
- 3.115
- +0.015+0.48%
Trading Apr 24 12:20 ET
16.67MMarket Cap-1557.50P/E (TTM)
3.215High3.110Low13.53KVolume3.100Open3.100Pre Close42.61KTurnover0.26%Turnover RatioLossP/E (Static)5.35MShares11.79052wk High0.79P/B16.17MFloat Cap2.75052wk Low--Dividend TTM5.19MShs Float1462.000Historical High--Div YieldTTM3.39%Amplitude2.310Historical Low3.148Avg Price1Lot Size
About Lipocine Company
Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.
Company Profile
SymbolLPCN
Company NameLipocine
Listing DateMar 21, 2014
Founded2011
CEODr. Mahesh V. Patel, PhD
MarketNASDAQ
Employees16
Fiscal Year Ends12-31
Address675 Arapeen Drive,Suite 202
CitySalt Lake City
ProvinceUtah
CountryUnited States of America
Zip Code84108
Phone1-801-994-7383
Websitehttp://www.lipocine.com
Company Executives
- Name
- Position
- Salary
- Dr. Mahesh V. Patel, PhD
- Director, President, Chief Executive Officer and Principal Financial Officer
- 761.77K
- Krista Fogarty
- Principal Accounting Officer and Corporate Controller
- 340.59K
- Nachiappan Chidambaram, PhD
- Senior Vice President, Research and Development
- 413.79K
- Dr. Spyros Papapetropoulos, M.D.,PhD
- Lead Independent Director and Chairman of the Board
- 102.22K
- John W. Higuchi, M.B.A.
- Director
- 64.72K
- Jeffrey A Fink, M.B.A.
- Independent Director
- 88.72K
- Dr. Richard Dana Ono, PhD
- Independent Director
- 84.72K
- Dr. Jill M. Jene, M.B.A.,PhD
- Independent Director
- 72.22K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call